[药物治疗在脑膜瘤治疗中的作用]
1Department of Neurosurgery, Keio University School of Medicine.
No shinkei geka. Neurological surgery
|July 22, 2024
概括
复发性脑膜瘤 (二/三级) 通常会抵抗当前的治疗. 新的全身疗法,包括向药物和免疫疗法,在这些具有挑战性的中枢神经系统瘤中显示出改善结果的希望.
科学领域:
- 神经瘤学神经瘤学
- 癌症遗传学 癌症遗传学
- 翻译医学是一种翻译医学.
背景情况:
- 脑膜瘤是最常见的中枢神经系统初级瘤.
- 高度 (2/3) 脑膜瘤具有显著的复发风险,尽管最大限度的治疗.
- 目前的全身疗法,包括分子向疗法,对耐火性或复发性脑膜瘤的疗效有限.
研究的目的:
- 审查目前的脑膜瘤全身治疗选择.
- 讨论最近在理解脑膜瘤遗传学和表观遗传学方面的进展.
- 探索新的治疗策略和正在进行的脑膜瘤临床试验.
主要方法:
- 关于脑膜瘤全身治疗的文献综述.
- 对脑膜瘤遗传学和表观遗传学的最新进展进行分析.
- 讨论新兴的治疗目标和临床试验.
主要成果:
- 针对生长因子的药物治疗已经显示出有限的有效性.
- 遗传和表观遗传改变正在导致新的分类和治疗点.
- 免疫检查点抑制剂在高瘤突变负担脑膜瘤中有效性有限.
- 结合疗法和新的方法,如CAR T细胞和型病毒免疫疗法正在研究中.
结论:
- 对于复发性和耐火性脑膜瘤,迫切需要新的全身治疗方法.
- 基于基因改变的精准医学具有治疗潜力.
- 对免疫疗法和基因疗法等新策略的进一步研究是有必要的.
相关概念视频
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Drug Delivery: Parenteral Route
470
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
470
Alzheimer's Disease: Treatment
172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Parkinson's Disease: Treatment
244
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
244


